You are not currently logged in.
Access JSTOR through your library or other institution:
Oral Acyclovir Therapy Accelerates Pain Resolution in Patients with Herpes Zoster: A Meta-Analysis of Placebo-Controlled Trials
M. J. Wood, R. Kay, R. H. Dworkin, S.-J. Soong and R. J. Whitley
Clinical Infectious Diseases
Vol. 22, No. 2 (Feb., 1996), pp. 341-347
Published by: Oxford University Press
Stable URL: http://www.jstor.org/stable/4459241
Page Count: 7
You can always find the topics here!Topics: Pain, Herpes zoster, Postherpetic neuralgia, Placebos, Exanthema, Age, Meta analysis, Experimentation, P values, Demography
Were these topics helpful?See somethings inaccurate? Let us know!
Select the topics that are inaccurate.
Preview not available
Meta-analysis of four double-blind, randomized, placebo-controlled trials of oral acyclovir (800 mg five times daily) for the treatment of herpes zoster was conducted to provide definitive assessments of the effect of acyclovir on the resolution of zoster-associated pain. The studies involved a total of 691 patients, and the analysis was performed on an intent-to-treat basis. A range of milestones of pain cessation were evaluated by means of Cox regression models with adjustment for relevant prognostic factors. The proportion of patients with postherpetic neuralgia at 3 and 6 months was also determined. Advancing age and more severe pain at presentation were associated with more prolonged pain. Acyclovir was clearly shown to accelerate pain resolution by all of the measures employed. Benefit was especially evident in patients 50 years of age or older. Fewer acyclovir recipients had postherpetic neuralgia at 3 or 6 months. Overall, the reductions of pain duration and prevalence were approximately twofold.
Clinical Infectious Diseases © 1996 Oxford University Press